Hongmei Yu, Ph.D.

n/a
Quantum Leap Healthcare Collaborative
San Francisco, California, United States

Presentation(s):

• 3: Oncologic Outcomes with De-Escalation of Axillary Surgery after Neoadjuvant Chemotherapy for Breast Cancer: Results from >1,500 patients on the I-SPY2 Clinical Trial

  Friday, March 22, 2024
  1:26pm – 1:38pm ET